Introduction
Bovine ephemeral fever virus (BEFV) is an arthropod-borne rhabdovirus which causes a disabling febrile infection of cattle and water buffalo. The disease is common in tropical and subtropical regions of Africa, Asia, Australia and the MiddleEast and is of major economic importance to dairy and grazing industries. BEFV is the type species of the genus Ephemerovirus which also presently includes Adelaide River virus and Berrimah virus, and tentatively Kimberley, Malakal and Puchong viruses (Wunner et al., 1995) . All of these viruses have been isolated from insects or associated with insect vectors. However, only BEFV is known to cause disease in vertebrates.
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(488)EEDE(491) and (499)NPHE(502). Site G2 mutations mapped either at aa 169 or 187. The 12 mutants representing antigenic site G3 (G3a and G3b) mapped to aa 49, 57, 218, 229 and 265, indicating that this site is likely to combine complex discontinuous epitopes. Comparison of the deduced amino acid sequence from five BEFV field isolates and BB7721 identified aa 218 to be critical for the site G3a neutralization. Alignment of the glycoproteins of rabies virus, vesicular stomatitis Indiana virus, vesicular stomatitis New Jersey virus, infectious haematopoietic necrosis virus and BEFV revealed similarities in the location of the neutralizing epitopes and extensive conservation of cysteine residues, suggesting that basic elements of the folded structure of these glycoproteins are preserved.
Like other rhabdoviruses, BEFV has a (k)ssRNA genome and five structural proteins including a nucleoprotein (N), a polymerase-associated protein (P), a matrix protein (M), a large RNA-dependent RNA polymerase (L) and a surface glycoprotein (G) (Walker et al., 1991) . The 81 kDa BEFV G protein is a class I transmembrane glycoprotein which contains typespecific and neutralizing antigenic sites (Cybinski et al., 1990) and induces protective immunity in cattle (Uren et al., 1994 ; Hertig et al., 1996) . BEFV and other ephemeroviruses also encode a second non-structural glycoprotein (G NS ) and several other small polypeptides (Walker et al., 1992 ; Wang & Walker, 1993 ; Wang et al., 1994 ; McWilliam et al., 1997) . The G NS glycoprotein is also a class I transmembrane glycoprotein which is structurally related to the G protein but has not been detected in virions and does not induce a neutralizing or protective immune response (Walker et al., 1991 (Walker et al., , 1992 Hertig et al., 1996) .
Four distinct neutralizing antigenic sites (G1, G2, G3 and G4) have been identified on BEFV G protein by competition binding studies using neutralizing monoclonal antibodies (MAbs) and cross-reactivity analysis of neutralization-resistant escape mutants (Cybinski et al., 1990 (Cybinski et al., , 1992 . Although BEFV appears to exist as a single serotype worldwide, an analysis of a number of Australian and Chinese isolates has revealed some antigenic variation at these sites (Cybinski et al., 1992 ; K. Kongsuwan and associates, unpublished) . Determining the nature of this variation will be important in understanding the epidemiology of BEFV infection and in the design of broadly protective vaccines. In this paper, we further characterize BEFV neutralization epitopes and locate amino acids which are critical for virus neutralization by an analysis of the structure of neutralization escape mutants and field strains isolated from various hosts and geographical locations in Australia. Overlapping octamer peptides encompassing the region identified as antigenic site G1 have also been examined to define two distinct B cell epitopes in this major linear site.
Methods

Growth of BEFV viruses and selection of escape mutants.
The production of BEFV G protein MAbs and the selection of neutralization escape mutants have been described elsewhere (Cybinski et al., 1990 (Cybinski et al., , 1992 . Briefly, the MAbs were prepared following injection of BALB\c mice with clarified BEFV (BB7721)-infected mouse brain. Neutralization-resistant escape mutants were selected from the same BEFV isolate following adaptation to cell culture. The mutants were selected from the natural virus population (i.e. without mutagenesis) following pre-incubation with and plaque assay in medium containing the selecting MAb. The five field strains of BEFV studied here were obtained from the virus collection of CSIRO Tropical Agriculture, Indooroopilly, Australia. The details of the passage level, host origin, place and year of collection have been described (Cybinski et al., 1992) . Viruses were propagated by infection of confluent monolayers of BHK-21 cells at an m.o.i. of 1-10 p.f.u. per cell. After 1 h absorption, BME medium containing 5 % FCS was added and cultures were incubated at 37 mC for 24-48 h before RNA extraction. Viral RNA isolation and PCR amplification. Sequences of the mutants were determined from PCR-amplified cDNA produced from cytoplasmic RNA from BEFV-infected cells. Total cytoplasmic RNAs were prepared from infected cells using RNAzol (Bresatec). cDNA from the G coding region was synthesized using approximately 1 µg of total RNA with primer EG2 (5' TACAACAGCAGATAAAAC 3') and 5 units of MMLV H − reverse transcriptase (Promega). The EG2 primer binds to the sequence at the 3' end of the G ectodomain (Walker et al., 1992) . The cDNA was amplified by Taq polymerase (Promega) and a hot start programme with EG1 and EG2 (5' AAGATTCATTTGGAGAAA 3') primers. The EG1 primer sequence was derived from the sequence at the 5' end of the G gene. After the initial denaturation at 94 mC for 4 min, the amplification proceeded through a total of 30 cycles consisting of denaturation at 94 mC (1 min), annealing at 55 mC (1 min), primer extension at 72 mC (1n5 min) and the final extension of 10 min at 72 mC. PCR products were purified with the Wizard PCR Clean-Up kit (Promega) and either subcloned into Srf I-digested pPCRscript SK vector (Stratagene) or pGEM-T vector (Promega) using standard techniques, or sequenced directly.
DNA sequencing. PCR products or plasmids containing inserts were sequenced using PRISM Cycle Sequencing (Applied Biosystems) with EG1, EG2 and internal primers covering the G ectodomain. Reactions were processed by using an Applied Biosystems automated DNA sequencer and analysed using the Applied Biosystems Seqed program. For each escape mutant two or more RT-PCR products or subclones were sequenced to eliminate errors introduced during amplification. Multiple sequence alignments were done with the CLUSTAL W software package (Thompson et al., 1994) and adjusted to account for obvious sequence similarities.
Mapping of epitopes with synthetic peptides. Fourteen octamer-peptides representative of the predicted G1 antigenic site covering aa 485-505 in the native BEFV G sequence were synthesized using the multipin peptide synthesis method. The peptides overlapped the preceding and subsequent peptides by one residue. The MAbs were assayed as culture supernatants or ascitic fluids diluted at 1 : 20 (MAbs 9C5 and 13C6) or 1 : 50 (MAbs DB5, 13A3 and 17B1). Pin peptides were precoated with 1 % gelatin and 1 % Tween 20 in 0n01 M PBS pH 7n2 for 1 h at room temperature to block non-specific absorption of antibodies. This was followed by a wash in 0n05 % Tween 20-PBS. The 2 h incubation at room temperature in a dilution of antiserum in pre-coat buffer was followed by four washes (10 min each on a shaker platform) with 0n05 % Tween 20-PBS. Reaction for 1 h at room temperature with a 1 : 3000 dilution of goat anti-mouse IgG coupled to horseradish peroxidase (Dakopatts) and 1 % sheep serum in precoat buffer was again followed by extensive washing to remove excess conjugate. The presence of antibody was detected by reaction with a freshly prepared substrate solution (0n5 mg\ml diammonium 2,2'-azino-bis[3-ethylbenzthiazoline 6-sulphonate] or ABTS, 0n01 M PBS and 0n01 % hydrogen peroxide) and the colour produced was read in a Titertek Multiskan Plus MKII plate reader at 405 nm. Prior to retesting, bound antibody was removed from pin peptides by sonicating in 0n1 M PBS-1 % SDS and 0n1 % 2-mercaptoethanol at 60 mC. The sample was then washed several times with distilled water (60 mC) before immersing in boiling methanol and air drying.
Results
Characterization of escape mutants
The pattern of cross-neutralization of BEFV escape mutants by the G protein MAbs was reported previously (Cybinski et al., 1992) . For clarity, these results have been reproduced in Fig.  1 and expanded to indicate the pattern of reactivities of the individual mutants. The mutants have been assigned to groups corresponding to four distinct antigenic sites that were defined by competitive binding assays (Cybinski et al., 1990 (Cybinski et al., , 1992 . Mutants selected by site G1 or site G2 MAbs were neutralized by all MAbs assigned to other sites, but were not neutralized by the selecting MAb, and often were totally or partially resistant to neutralization by other MAbs assigned to the same site. Antigenic site G3 was defined by competitive binding assays (Cybinski et al., 1990) as a complex site comprising two elements (G3a and G3b). Site G3a MAbs 8B6 and 3D6 competed for antigen binding and selected mutants that were resistant to cross-neutralization. Site G3b MAbs 16A6 and 8D3 also competed in antigen binding assays but selected escape mutants that failed to be cross-neutralized. MAb 8D3 also competed with both 8B6 and 3D6 for antigen binding, establishing the relationship between sites G3a and G3b. Antigenic site G4 was defined by a single MAb (5A5) which failed to compete with other MAbs for antigen binding and selected a unique escape mutant (Cybinski et al., 1990 (Cybinski et al., , 1992 .
Thirty-three neutralization escape mutants representing sites G1, G2, G3a and G3b were examined by sequence analysis of the 1527 nt region encoding the entire ectodomain of the G protein. The region encoded 509 aa between the signal peptide and the transmembrane domain (aa 18-521) of the G protein. The nucleotide and deduced amino acid sequences of the mutants were compared with those of the parental BEFV isolate BB7721 (Walker et al., 1992) . Point mutations resulting in a single amino acid substitution were detected in each mutant ( sites is in accordance with the resistance of site G3b mutants to cross-neutralization (Fig. 1) .
Natural variants
An analysis of BEFV isolates recovered in Australia from naturally infected cattle and insects between 1956 and 1989 has indicated that 13 of 18 isolates failed to react with MAb 3D6. However, all isolates were neutralized by BEFV polyclonal mouse antiserum and MAbs 17B1 and 12A5 (Cybinski et al., 1992) . Five isolates were selected for sequence analysis of the 1527 nt region encoding the ectodomain of the G protein. Two isolates (CS42\Beatrice Hill\1975 ; CS1818\Upper Barron\1970) and the reference strain (BB7721\Charters Towers\1968) were sensitive to neutralization by MAb 3D6. Three isolates (CS1180\Peachester\1982, CS1619\ Peachester\1984 ; CS1647\Peachester\1984) were 3D6-resistant. The deduced amino acid sequence of the isolates is compared with that of BB7721 in Fig. 2 . All changes in the deduced protein sequence resulted from single nucleotide substitutions except for a complete codon deletion in isolate CS1619 at aa N'". No insertions or frameshifts were observed. Among the six isolates studied, there was 98-99 % nucleotide sequence identity and 96-98 % amino acid sequence identity. The only amino acid substitution peculiar to all three 3D6-resistant viruses was a conservative change at aa 218 (R to K). Substitutions at R#") were also found in experimentally derived 3D6-resistant mutants selected with both MAbs 3D6 and 8B6 (Table 1) , confirming the essential contribution of this arginine residue to antigenic site G3a.
No other substitutions in the isolates were detected at residues identified in escape mutants as critical to antigenic sites G1, G2 or G3b. However, several substitutions were detected in residues located at sites adjacent to critical residues. In particular, substitutions at aa 215 (K to T) and aa 263 (E to K) were adjacent to critical site G3a aa R#") and Q#'& respectively, and substitutions at aa 488 (R to K) immediately preceded the linear antigenic site G1. Despite their proximity to critical sites, none of these substitutions changed the neutralization characteristics of the isolates.
Location of B cell epitopes in the G1 antigenic site
Fourteen overlapping, polypropylene pin-bound octapeptides covering antigenic site G1 were assayed for reactivity with MAbs 13A3, DB5, 9C5, 17B1 and 13C6 by ELISA (Fig.  3) . The peptides, offset by one residue, spanned aa 485-505 of the G protein. Minimal B cell epitopes recognized by the MAbs were determined from the overlap of ELISA-positive peptide sequences. In the case of 13A3 and 9C5, the minimal epitope may include one extra residue not positively identified with the available synthetic peptides. The MAbs clustered into two subsets which recognized the N terminus (9C5, 17B1, 13C6) or the C terminus (13A3, DB5) of the antigenic site. The subsets corresponded to those identified by neutralization cross-reactions (Fig. 1 ) and sequence analysis (Table 1) G1 escape mutants. The extent of each B cell epitope determined from peptide binding, and neutralization and sequence analysis of escape mutants are summarized in Fig. 4 . The analysis indicated that critical residues required for generation of escape mutants and virus neutralization are not confined to the minimal epitope recognized in peptide ELISA. This indicates that, although the antigenic site is linear and Fig. 4 . Analysis of antigenic site G1 B cell epitopes. The sequence of 21 aa corresponding to antigenic site G1 of BEFV strain BB7721 and residues associated with neutralization or peptide binding of each MAb are shown. Square box, residue selected in escape mutant by neutralizing MAb ; circle, residue selected in escape mutant crossneutralized by MAb ; dashed circle, residue selected in escape mutant partially cross-neutralized by MAb ; underlined, residue assigned to minimal epitope from overlap of positive reactions with synthetic peptides ; dashed underline, residue tentatively assigned to minimal epitope from positive reaction with terminal synthetic peptide.
comprises two distinct epitopes, local conformation determined by the central region affects antibody binding to the terminal sites.
Alignment of rhabdovirus antigenic sites
A CLUSTAL W alignment of the deduced amino acid sequences of the G proteins of BEFV, VSV Indiana, VSV New Jersey, IHNV and rabies virus is shown in Fig. 5 . As described previously, the alignment has been adjusted to align putative signal peptides, transmembrane domains and common glycosylation sites, and illustrates the extensive conservation of cysteine residues which stabilize the folded structure of the glycoproteins (Walker et al., 1992) . Also indicated for each virus are amino acids which have been identified using escape mutants as influencing antibody binding to neutralization sites. As observed previously for a smaller set of viruses (Huang et al., 1996) , the critical residues are mostly clustered into a small number of aligned sites. In particular, residues contributing to the major discontinuous neutralization site of rabies virus (site II), IHNV (site II) and BEFV (site G3) align in three small regions that are distantly located in the amino acid chain. These three regions also encompass identified neutralization epitopes of VSV New Jersey (epitopes VI, VII and VIII) and VSV Indiana (epitopes A " and A # ). The remaining neutralization sites of VSV Indiana (epitope V) and VSV New Jersey (epitope B) appear to correspond to rabies virus antigenic site III (Vandepol et al., 1986 ; Luo et al., 1988 ; Seif et al., 1985 ; Prehaud et al., 1988) . Linear antigenic site G1 and discontinuous site G2 of BEFV do not appear to have been identified in other rhabdoviruses.
Discussion
The BEFV G protein, like those of other rhabdoviruses, is the major protective antigen and the site for binding of neutralizing antibody. This study defines amino acid residues which are important in determining the integrity of epitopes in the three major neutralization sites (G1, G2 and G3), allowing localization of the sites in the G protein sequence. The G1 BEFV neutralization epitopes BEFV neutralization epitopes Fig. 5 . Alignment of the deduced amino acid sequences of the G proteins of BEFV strain BB7721, rabies virus strain CVS (RABV), VSV Indiana (VSIV), VSV New Jersey (VSNV) and IHNV WRAC strain (IHNV). Signal sequences, transmembrane domains, BEFV antigenic sites G1, G2 and G3, and rabies antigenic site III are identified with a line above the sequence. The antigenic sites are not precisely defined but indicative of the general location in the sequence. Putative glycosylation sites are underlined. Amino acids that have been identified in escape mutants as influencing the structure of a neutralizing epitope are shown in bold and underlined. Positions of universally conserved amino acids are shown by the single-letter code below the aligned residue. Highly conserved cysteine residues are also indicated (*).
antigenic site is located in a linear stretch of 17 aa (Y%)(to K&!$) of the ectodomain adjacent to the transmembrane anchor. Corresponding sites have not been identified in other rhabdoviruses. However, the BEFV G protein is significantly larger than those of other known rhabdoviruses and sequence alignments indicate that this is due to an extension of the G protein stem between the transmembrane domain and the cysteine-rich head region (Walker et al., 1992 ; Gaudin et al., 1992) . The BEFV G1 antigenic site lies within this domain at a locus that does not align with other G protein sequences and appears to be one of two sites of stem elongation.
The linear conformation of the G1 site was suggested previously by Western blotting studies with G1-specific MAbs which reacted with the G protein following denaturation under reducing conditions. However, pepscan analysis, as well as neutralization cross-reactions and sequence analysis of escape mutants, indicate that G1 is more complex, comprising two overlapping domains. MAbs 17B1, 9C5 and 13C6 recognize epitopes in the N-terminal region (aa 487-495) which features the highly acidic sequence EEDE. Epitopes recognized by MAbs DB5 and 13A3 mapped to aa 493-503 and recognized a common minimal epitope consisting of the sequence NPHE. Furthermore, the size of minimal epitopes varied and those recognized by MAbs DB5, 17B1 and 13C6 were longer than those commonly found for linear B cell epitopes, suggesting some tertiary structure in this region of the molecule. The DB5 epitope mapped to 11 residues (Fig. 5 ) and contained two proline residues (P%*& and P&!!) which are a common feature in antigenic β-turns. Epitope 17B1 comprised 8 residues and 13A6 comprised 9 residues, again suggesting conformation. (Hutchinson & Thornton, 1994) , the G1 site would not be considered linear and must involve some local conformation. Secondary structure and solvent accessibility predictions indicate that the G1 sequence is likely to be a loop (data not shown). This would account for the high proportion of mutants with amino acid substitutions in this region exposed to immune selection. The observations also support previous studies which suggest that far fewer residues are necessary for specific recognition than the total number of residues in the contact region of the antibody (Geysen et al., 1984 ; Getzoff et al., 1987 ; Jin et al., 1992 ; Speller et al., 1993) .
The G2 and G3 neutralization sites are located in the cysteine-rich head portion of the G protein ectodomain (Fig. 5) . The non-linear conformation of these sites was suggested previously by Western blotting studies (Cybinski et al., 1990) . Site G2 encompasses residues L"'* and I")(, intersected by two cysteine residues (C"(# and C")#) which are conserved in all animal rhabdoviruses other than sigma virus. Modelling studies suggest that they are likely to form a disulphide bridge which would align the components of the G2 site at the base of an Nglycosylated loop (P. J. Walker & K. Kongsuwan, unpublished) . A conservative substitution (I to M) at aa 187 produced resistance only to the selecting MAb (12A5), but a nonconservative substitution (I to R) selected by the same antibody produced a mutant that was resistant to neutralization by all G2 MAbs ( Fig. 1 ; Table 1 ). It has been reported previously for rabies virus that the nature of amino acid substitutions at the same site is important in determining their accessibility to neutralizing antibodies (Prehaud et al., 1988) .
Antigenic site G3 comprises amino acid residues which are distributed at distant loci in the cysteine-rich head domain and appears to correspond to the major conformational site identified in the G proteins of other animal rhabdoviruses. Site G3a MAbs 3D6 and 8B6, which compete for antigen binding, each selected neutralization escape mutations at residues D&( and R#"). The critical role of R#") in antibody binding to the site was supported by the study of BEFV field isolates. MAb 3D6 also selected a mutation at Q#'& which remained susceptible to neutralization by MAb 8B6. Site G3b MAbs 16A6 and 8D3, which also compete for antigen binding, selected respective mutations at Q%* and E##* that were not cross-resistant to neutralization. MAbs representing sites G3a and G3b also competed for antigen binding and selected escape mutants in similar regions but there was no crossresistance between the mutants. This suggests that elements of the G3 site are derived from three distant regions of the polypeptide chain represented by residues Q%* and D&( ; R#") and E##* ; and Q#'&. Competitive binding and cross-neutralization data indicate that these regions are closely associated in the folded protein to form a complex neutralization site comprising several distinct epitopes. Similar complex nonlinear neutralization sites have been recognized in the G proteins of other rhabdoviruses. Alignment of the G protein sequences indicates that there is a remarkable correspondence between the locations of site G3 mutations and those of site II in rabies (Prehaud et al., 1988) , epitope A in VSV Indiana (Vandepol et al., 1986) , epitope VII of VSV New Jersey (Luo et al., 1988 ; and sites I and II in IHNV (Huang et al., 1996) (Fig. 5) . As reported previously, there is also a remarkable degree of conservation of cysteine residues in these proteins and, despite the low level of amino acid sequence identity, basic elements of the folded structure of animal rhabdovirus G proteins appear to be preserved (Walker et al., 1992 ; Huang et al., 1996) .
Potential sites for N-linked glycosylation lie adjacent to all three BEFV neutralization sites. Indeed, aa Q#'& in site G3 forms part of the N-glycosylation recognition sequence (NQT). The proximity of glycosylation and antigenic sites has been observed for other rhabdoviruses and this is not surprising as each is likely to be located on the external surface of the protein. However, there is evidence that some potential sites may not be glycosylated (Benmansour et al., 1991) and that glycosylation may influence the folded conformation of the G protein (Grigera et al., 1991) . The role of glycosylation in neutralization site recognition or in protection from protease digestion has yet to be established.
Neutralizing MAbs have previously been shown to induce a significant protective response in mice against lethal BEFV challenge (Cybinski et al., 1990) . Purified BEFV G protein and G protein expressed from recombinant vaccinia virus have also been shown to protect cattle from experimental challenge and there was a correlation between protection and the presence of neutralizing antibody (Uren et al., 1994 ; Hertig et al., 1996) . The G1 neutralization site is located in a linear sequence close to the transmembrane domain. Although the site may involve some local conformation, G1 epitopes remain accessible in reduced G protein and in synthetic peptides used for pepscan analysis. We have found that G1 epitopes are preserved in 70 Australian BEFV isolates obtained from different geographical locations during the period 1956-1992 and sequence analysis of representative isolates indicates that site is highly conserved (unpublished data). There appears potential to use the G1 site as the basis of a synthetic peptide vaccine.
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